Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas.
Sep 8, 2023, 12:49

Amar Gajjar: SJ901 offers a new targeted therapeutic approach against pediatric low-grade gliomas.

Quoting Amar Gajjar on Twitter:

SJ901, named after the last 3 digits of the experimental SpringWorks drug, offers a new targeted therapeutic approach against pediatric low-grade gliomas. Giles Robinson.”

For the article click here.
Source: Amar Gajjar/Twitter